Baroda BNP Paribas Innovation Fund
(An open-ended equity scheme investing in innovation theme)
Baroda BNP Paribas Innovation Fund
(An open-ended equity scheme investing in innovation theme)
July 2025

July 2025


Investment Objective

The investment objective of the scheme is to seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of companies focusing and benefitting from innovation. However, there is no assurance that the investment objective of the Scheme will be achieved.

NAV Details (As on July 31, 2025)
Regular Plan - IDCW Option : ₹ 12.0568
Regular Plan - Growth Option : ₹12.1794
Direct Plan - IDCW Option : ₹ 12.4565
Direct Plan - Growth Option : ₹12.4565
 
Benchmark Index (AMFI Tier 1)

Nifty 500 TRI

Date of Allotment

March 5, 2024

Fund Manager
Fund Manager Managing fund since Experience
Mr. Pratish Krishnan 5-Mar-24 23 years
Mr. Ankeet Pandya 01-Jan-25 11 years
Load Structure

Exit Load: • If units of the Scheme are redeemed or switched out up to 10% of the units within 1 year from the date of allotment - Nil. • If units of the scheme are redeemed or switched out in excess of the limit within 1 year from the date of allotment - 1% of the applicable NAV. • If units of scheme are redeemed or switched out after 1 year from the date of allotment - Nil.

For detailed load structure please refer Scheme Information Document.

Lumpsum Details

Minimum Amount: Lumpsum investment:
₹ 1,000 and in multiples of ₹ 1 thereafter.
Minimum Additional Application Amount:₹ 1,000 and in multiples of ₹ 1 thereafter.


Monthly AAUM## As on July 31, 2025 : ₹ 991.71 Crores
AUM## As on July 31, 2025 : ₹ 976.35 Crores

## including inter-scheme Investments, if any, by other schemes of Baroda BNP Paribas Mutual Fund, as may be applicable

EQUITY HOLDINGS % of Net Assets
Retailing 11.99%
Eternal Limited 3.77%
Info Edge (India) Limited 2.58%
Swiggy Limited 2.19%
FSN E-Commerce Ventures Limited 1.91%
Trent Limited 1.54%
Pharmaceuticals & Biotechnology 8.95%
Sun Pharmaceutical Industries Limited 2.97%
Divi's Laboratories Limited 2.65%
Concord Biotech Limited 2.11%
Pfizer Limited 1.22%
Chemicals & Petrochemicals 7.98%
Linde India Limited 3.89%
Navin Fluorine International Limited 2.57%
Archean Chemical Industries Limited 1.52%
Automobiles 6.89%
TVS Motor Company Limited 3.39%
Mahindra & Mahindra Limited 2.07%
Hyundai Motor India Ltd 1.43%
Financial Technology (Fintech) 6.44%
PB Fintech Limited 3.43%
One 97 Communications Limited 3.01%
Capital Markets 6.03%
Multi Commodity Exchange of India Limited 2.15%
KFin Technologies Limited 2.00%
Computer Age Management Services Limited 1.88%
IT - Software 4.63%
Infosys Limited 1.94%
KPIT Technologies Limited 1.52%
Hexaware Technologies Limited 1.17%
Telecom - Services 4.18%
Bharti Airtel Limited 4.18%
Electrical Equipment 3.94%
Hitachi Energy India Limited 3.94%
Banks 3.87%
ICICI Bank Limited 3.87%
Industrial Manufacturing 3.67%
Tega Industries Limited 2.08%
Honeywell Automation India Limited 1.59%
Leisure Services 3.23%
Travel Food Services Limited 1.87%
TBO Tek Limited 1.36%
Industrial Products 2.74%
Cummins India Limited 2.74%
Auto Components 2.68%
Bosch Limited 1.88%
Jtekt India Limited 0.80%
Food Products 2.45%
Mrs. Bectors Food Specialities Limited 2.45%
Insurance 2.21%
Max Financial Services Limited 2.21%
Consumer Durables 2.20%
Amber Enterprises India Limited 2.20%
Diversified 2.19%
3M India Limited 2.19%
Petroleum Products 2.10%
Reliance Industries Limited 2.10%
Finance 2.08%
Bajaj Finance Limited 2.08%
Transport Services 1.60%
InterGlobe Aviation Limited 1.60%
IT - Services 1.43%
Sagility India Limited 1.43%
Fertilizers & Agrochemicals 1.15%
PI Industries Limited 1.15%
LESS THAN 0.75% EXPOSURE 0.46%
FUTURES LONG POSITION 0.47%
Infosys Limited 0.47%
TOTAL EQUITY HOLDING 95.56%
FIXED INCOME HOLDINGS Rating % of Net Assets
Treasury Bill 1.01%
182 Days Tbill (MD 23/10/2025) SOV 1.01%
Total Fixed Income Holdings 1.01%
TREPS, Cash & Other Net Current Assets 3.43%
GRAND TOTAL 100.00%

Investment in Top 10 scrips constitutes 35.19% of the portfolio


For SIP Performance please click here

For Scheme Performance please click here


Pursuant to distribution under Income Distribution cum Capital Withdrawal (‘IDCW’) option, NAV of the IDCW option of the scheme(s) would fall to the extent of payout and statutory levy (if applicable). The amounts under IDCW options can be distributed out of investors capital (Equalization Reserve), which is part of sale price that represents realized gains. Past performance may or may not be sustained in future. The above stated distribution rate per unit is net distribution rate after deducting applicable taxes. The above distribution rates are on face value of ₹ 10 per unit.

TER - Regular Plan (%) 2.26%
TER - Direct Plan (%) 1.06%
Portfolio Turnover Ratio 0.70

* The information contained in this report has been obtained from sources considered to be authentic and reliable. This quantitative data does not purport to be an offer for purchase and sale of mutual fund units.

No of Stocks 44
Portfolio RoE (%) 17.79
EPS Growth (%) 37.32

This product is suitable for investors who are seeking*:

➤ Long term capital appreciation
➤ Investment in equity & equity related securities of the companies that benefit from innovation theme.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Scheme Riskometer^^
Investors understand that their principal will be at Very High risk


Benchmark (Tier 1) Riskometer^
Benchmark riskometer is at Very High risk


^^Riskometer For Scheme: basis it’s portfolio, ^Riskometer For Benchmark (Nifty 500 TRI): basis it’s constituents; As on July 31, 2025

For complete portfolio, kindly refer the website https://www.barodabnpparibasmf.in/
Mutual Fund investments are subject to market risks, read all scheme related documents carefully.